FDA 483 - BioLife Plasma Services L P - May 27, 2022

BioLife Plasma Services L P in Rialto, CA, was inspected by the FDA from May 24-27, 2022. The inspection revealed that employees failed to consistently follow written standard operating procedures for the setup of plasmapheresis machines. This indicates a procedural adherence issue in the collection of blood and blood components.